Productivity and deadweight losses due to relapses of schizophrenia in Japan

Yusuke Nakamura,1 Jörg Mahlich1,2 1Health Economics, Janssen Pharmaceutical K.K., Tokyo, Japan; 2Düsseldorf Institute for Competition Economics (DICE), University of Düsseldorf, Düsseldorf, Germany Background: No study has examined the financial impact of relaps...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Nakamura Y, Mahlich J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	Schizophrenia Relapses Societal Costs Productivity Loss Deadweight Loss Japan Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/4f9c68aed75e4fc39ef23d28098ead01
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4f9c68aed75e4fc39ef23d28098ead01
record_format	dspace
spelling	oai:doaj.org-article:4f9c68aed75e4fc39ef23d28098ead012021-12-02T02:09:25ZProductivity and deadweight losses due to relapses of schizophrenia in Japan1178-2021https://doaj.org/article/4f9c68aed75e4fc39ef23d28098ead012017-05-01T00:00:00Zhttps://www.dovepress.com/productivity-and-deadweight-losses-due-to-relapses-of-schizophrenia-in-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Yusuke Nakamura,1 Jörg Mahlich1,2 1Health Economics, Janssen Pharmaceutical K.K., Tokyo, Japan; 2Düsseldorf Institute for Competition Economics (DICE), University of Düsseldorf, Düsseldorf, Germany Background: No study has examined the financial impact of relapses on schizophrenia from the perspective of Japanese society. This study aimed to estimate the societal costs in Japan caused by the relapses of schizophrenia.Methods: The societal costs in Japan in 2013 due to relapses of schizophrenia were estimated by summing the productivity loss and deadweight loss caused by schizophrenia relapses in 2013. Deterministic sensitivity analysis was conducted for deadweight loss rate, relapse rate, and patient income.Results: Japan incurred JPY 55,039 million societal costs because of relapses in 2013. This consists of JPY 3,990 million for productivity loss and JPY 51,049 million for deadweight loss. Rate of deadweight loss is the most significant cost driver in the sensitivity analysis.Conclusion: Relapses of schizophrenia could generate huge amount of societal costs by reducing labor productivity and economic efficiency. To curb these costs, relapse prevention is desired in treating schizophrenia. Keywords: schizophrenia, relapses, societal costs, productivity loss, deadweight loss, Japan Nakamura YMahlich JDove Medical PressarticleSchizophreniaRelapsesSocietal CostsProductivity LossDeadweight LossJapanNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 13, Pp 1341-1348 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Schizophrenia Relapses Societal Costs Productivity Loss Deadweight Loss Japan Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Schizophrenia Relapses Societal Costs Productivity Loss Deadweight Loss Japan Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Nakamura Y Mahlich J Productivity and deadweight losses due to relapses of schizophrenia in Japan
description	Yusuke Nakamura,1 Jörg Mahlich1,2 1Health Economics, Janssen Pharmaceutical K.K., Tokyo, Japan; 2Düsseldorf Institute for Competition Economics (DICE), University of Düsseldorf, Düsseldorf, Germany Background: No study has examined the financial impact of relapses on schizophrenia from the perspective of Japanese society. This study aimed to estimate the societal costs in Japan caused by the relapses of schizophrenia.Methods: The societal costs in Japan in 2013 due to relapses of schizophrenia were estimated by summing the productivity loss and deadweight loss caused by schizophrenia relapses in 2013. Deterministic sensitivity analysis was conducted for deadweight loss rate, relapse rate, and patient income.Results: Japan incurred JPY 55,039 million societal costs because of relapses in 2013. This consists of JPY 3,990 million for productivity loss and JPY 51,049 million for deadweight loss. Rate of deadweight loss is the most significant cost driver in the sensitivity analysis.Conclusion: Relapses of schizophrenia could generate huge amount of societal costs by reducing labor productivity and economic efficiency. To curb these costs, relapse prevention is desired in treating schizophrenia. Keywords: schizophrenia, relapses, societal costs, productivity loss, deadweight loss, Japan
format	article
author	Nakamura Y Mahlich J
author_facet	Nakamura Y Mahlich J
author_sort	Nakamura Y
title	Productivity and deadweight losses due to relapses of schizophrenia in Japan
title_short	Productivity and deadweight losses due to relapses of schizophrenia in Japan
title_full	Productivity and deadweight losses due to relapses of schizophrenia in Japan
title_fullStr	Productivity and deadweight losses due to relapses of schizophrenia in Japan
title_full_unstemmed	Productivity and deadweight losses due to relapses of schizophrenia in Japan
title_sort	productivity and deadweight losses due to relapses of schizophrenia in japan
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/4f9c68aed75e4fc39ef23d28098ead01
work_keys_str_mv	AT nakamuray productivityanddeadweightlossesduetorelapsesofschizophreniainjapan AT mahlichj productivityanddeadweightlossesduetorelapsesofschizophreniainjapan
_version_	1718402647717838848

Productivity and deadweight losses due to relapses of schizophrenia in Japan

Ejemplares similares